nodes	percent_of_prediction	percent_of_DWPC	metapath
Anisotropine Methylbromide—CHRM3—ureter—prostate cancer	0.272	0.625	CbGeAlD
Anisotropine Methylbromide—Valproic Acid—UGT2B15—prostate cancer	0.051	0.485	CrCbGaD
Anisotropine Methylbromide—CHRM2—prostate gland—prostate cancer	0.039	0.0895	CbGeAlD
Anisotropine Methylbromide—CHRM1—prostate gland—prostate cancer	0.0355	0.0815	CbGeAlD
Anisotropine Methylbromide—CHRM3—prostate gland—prostate cancer	0.0317	0.0729	CbGeAlD
Anisotropine Methylbromide—CHRM3—renal system—prostate cancer	0.0216	0.0497	CbGeAlD
Anisotropine Methylbromide—CHRM3—urethra—prostate cancer	0.0212	0.0488	CbGeAlD
Anisotropine Methylbromide—Valproic Acid—CYP2C18—prostate cancer	0.0168	0.16	CrCbGaD
Anisotropine Methylbromide—CHRM3—testis—prostate cancer	0.014	0.0321	CbGeAlD
Anisotropine Methylbromide—Valproic Acid—CYP3A5—prostate cancer	0.0111	0.105	CrCbGaD
Anisotropine Methylbromide—Valproic Acid—CYP2A6—prostate cancer	0.0107	0.102	CrCbGaD
Anisotropine Methylbromide—Valproic Acid—CYP2C19—prostate cancer	0.00754	0.0717	CrCbGaD
Anisotropine Methylbromide—Valproic Acid—CYP3A4—prostate cancer	0.00479	0.0456	CrCbGaD
Anisotropine Methylbromide—Ipratropium bromide—CYP3A4—prostate cancer	0.00319	0.0304	CrCbGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—PIK3CD—prostate cancer	0.000129	0.00028	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—PIK3CD—prostate cancer	0.000128	0.000279	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—TYMS—prostate cancer	0.000127	0.000277	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PRKCQ—prostate cancer	0.000127	0.000277	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—NGFR—prostate cancer	0.000127	0.000277	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—PIK3CD—prostate cancer	0.000127	0.000276	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PRKCQ—prostate cancer	0.000127	0.000276	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—NGFR—prostate cancer	0.000127	0.000276	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—GSTM1—prostate cancer	0.000126	0.000274	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MAP3K7—prostate cancer	0.000126	0.000273	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—NGFR—prostate cancer	0.000126	0.000273	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PRKCQ—prostate cancer	0.000126	0.000273	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MAP3K7—prostate cancer	0.000125	0.000273	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MAP3K7—prostate cancer	0.000124	0.00027	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—LPL—prostate cancer	0.000124	0.000269	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—FGF10—prostate cancer	0.000121	0.000263	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—FGF10—prostate cancer	0.00012	0.000262	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—ADRB2—prostate cancer	0.00012	0.00026	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—CYP1A1—prostate cancer	0.000119	0.00026	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—FGF10—prostate cancer	0.000119	0.00026	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—ADRB2—prostate cancer	0.000119	0.000259	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—ERCC2—prostate cancer	0.000118	0.000258	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—ADRB2—prostate cancer	0.000118	0.000257	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—JAK2—prostate cancer	0.000118	0.000257	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—JAK2—prostate cancer	0.000118	0.000256	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—MAP2K1—prostate cancer	0.000117	0.000256	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—MAP2K1—prostate cancer	0.000117	0.000255	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—PIK3CD—prostate cancer	0.000117	0.000254	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—VAV3—prostate cancer	0.000117	0.000254	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—JAK2—prostate cancer	0.000116	0.000253	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—PIK3CD—prostate cancer	0.000116	0.000253	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—VAV3—prostate cancer	0.000116	0.000253	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—MAP2K1—prostate cancer	0.000116	0.000252	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—PIK3CD—prostate cancer	0.000115	0.000251	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—VAV3—prostate cancer	0.000115	0.00025	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TGFBR2—prostate cancer	0.000115	0.00025	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TGFBR2—prostate cancer	0.000115	0.000249	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TGFBR2—prostate cancer	0.000113	0.000247	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—ITPR1—prostate cancer	0.000113	0.000246	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—ITPR1—prostate cancer	0.000113	0.000245	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—PIK3CB—prostate cancer	0.000112	0.000244	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—PIK3CB—prostate cancer	0.000112	0.000243	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—ITPR1—prostate cancer	0.000112	0.000243	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—MTHFR—prostate cancer	0.000111	0.000242	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—PIK3CB—prostate cancer	0.000111	0.000241	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PPARA—prostate cancer	0.000109	0.000238	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IGF1R—prostate cancer	0.000108	0.000235	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IGF1R—prostate cancer	0.000108	0.000235	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—CXCL8—prostate cancer	0.000108	0.000234	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—CXCL8—prostate cancer	0.000107	0.000233	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—JAK2—prostate cancer	0.000107	0.000233	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—JAK2—prostate cancer	0.000107	0.000232	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IGF1R—prostate cancer	0.000107	0.000232	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—CXCL8—prostate cancer	0.000106	0.000231	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—JAK2—prostate cancer	0.000106	0.00023	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—LPL—prostate cancer	0.000104	0.000226	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—LPL—prostate cancer	0.000103	0.000225	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—IL2—prostate cancer	0.000103	0.000224	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PDGFRB—prostate cancer	0.000103	0.000224	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—CAV1—prostate cancer	0.000103	0.000223	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—IL2—prostate cancer	0.000103	0.000223	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PDGFRB—prostate cancer	0.000102	0.000223	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—LPL—prostate cancer	0.000102	0.000223	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—PIK3CB—prostate cancer	0.000102	0.000221	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—IL2—prostate cancer	0.000102	0.000221	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PDGFRB—prostate cancer	0.000101	0.000221	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—PIK3CB—prostate cancer	0.000101	0.000221	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—PIK3CB—prostate cancer	0.0001	0.000218	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—ITGB3—prostate cancer	0.0001	0.000218	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—ITGB3—prostate cancer	9.98e-05	0.000217	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—ITGB3—prostate cancer	9.88e-05	0.000215	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—CXCL8—prostate cancer	9.78e-05	0.000213	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—CXCL8—prostate cancer	9.75e-05	0.000212	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—ERBB3—prostate cancer	9.71e-05	0.000211	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—FGFR2—prostate cancer	9.7e-05	0.000211	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—ERBB3—prostate cancer	9.68e-05	0.000211	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—FGFR2—prostate cancer	9.67e-05	0.00021	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—CXCL8—prostate cancer	9.65e-05	0.00021	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—ERBB3—prostate cancer	9.59e-05	0.000209	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—FGFR2—prostate cancer	9.57e-05	0.000208	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PIK3CG—prostate cancer	9.35e-05	0.000203	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—IL2—prostate cancer	9.34e-05	0.000203	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—IL2—prostate cancer	9.31e-05	0.000203	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TERT—prostate cancer	9.31e-05	0.000203	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TERT—prostate cancer	9.28e-05	0.000202	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—IL2—prostate cancer	9.22e-05	0.000201	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TERT—prostate cancer	9.19e-05	0.0002	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HIF1A—prostate cancer	8.9e-05	0.000194	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HIF1A—prostate cancer	8.87e-05	0.000193	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—INS—prostate cancer	8.85e-05	0.000193	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HIF1A—prostate cancer	8.79e-05	0.000191	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—LEP—prostate cancer	8.69e-05	0.000189	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—CREBBP—prostate cancer	8.67e-05	0.000189	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—LEP—prostate cancer	8.66e-05	0.000188	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CAV1—prostate cancer	8.61e-05	0.000187	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CAV1—prostate cancer	8.58e-05	0.000187	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—LEP—prostate cancer	8.58e-05	0.000187	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—KDR—prostate cancer	8.51e-05	0.000185	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CAV1—prostate cancer	8.5e-05	0.000185	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—KDR—prostate cancer	8.49e-05	0.000185	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—KDR—prostate cancer	8.4e-05	0.000183	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—ESR1—prostate cancer	8.3e-05	0.000181	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—ESR1—prostate cancer	8.27e-05	0.00018	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PIK3CD—prostate cancer	8.22e-05	0.000179	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—ESR1—prostate cancer	8.19e-05	0.000178	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—BAD—prostate cancer	8.1e-05	0.000176	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—BAD—prostate cancer	8.07e-05	0.000176	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—BAD—prostate cancer	7.99e-05	0.000174	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—APC—prostate cancer	7.84e-05	0.000171	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PIK3CG—prostate cancer	7.84e-05	0.000171	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—APC—prostate cancer	7.82e-05	0.00017	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PIK3CG—prostate cancer	7.82e-05	0.00017	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—NOS3—prostate cancer	7.76e-05	0.000169	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—EGF—prostate cancer	7.75e-05	0.000169	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IRS1—prostate cancer	7.75e-05	0.000169	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PIK3CG—prostate cancer	7.74e-05	0.000168	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—APC—prostate cancer	7.74e-05	0.000168	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—EGF—prostate cancer	7.73e-05	0.000168	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IRS1—prostate cancer	7.73e-05	0.000168	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IRS1—prostate cancer	7.65e-05	0.000166	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—EGF—prostate cancer	7.65e-05	0.000166	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—GSK3B—prostate cancer	7.53e-05	0.000164	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—GSK3B—prostate cancer	7.5e-05	0.000163	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—GSK3B—prostate cancer	7.43e-05	0.000162	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—INS—prostate cancer	7.42e-05	0.000162	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—INS—prostate cancer	7.4e-05	0.000161	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—INS—prostate cancer	7.33e-05	0.000159	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CREBBP—prostate cancer	7.27e-05	0.000158	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CREBBP—prostate cancer	7.25e-05	0.000158	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IGF1—prostate cancer	7.18e-05	0.000156	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CREBBP—prostate cancer	7.18e-05	0.000156	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PIK3CB—prostate cancer	7.16e-05	0.000156	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IGF1—prostate cancer	7.16e-05	0.000156	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—EGFR—prostate cancer	7.15e-05	0.000155	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—EGFR—prostate cancer	7.12e-05	0.000155	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PTGS2—prostate cancer	7.1e-05	0.000154	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IGF1—prostate cancer	7.09e-05	0.000154	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—EGFR—prostate cancer	7.05e-05	0.000153	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MAP2K1—prostate cancer	6.94e-05	0.000151	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MAP2K1—prostate cancer	6.92e-05	0.000151	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PIK3CD—prostate cancer	6.9e-05	0.00015	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PIK3CD—prostate cancer	6.87e-05	0.00015	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MAP2K1—prostate cancer	6.85e-05	0.000149	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—PIK3CA—prostate cancer	6.83e-05	0.000149	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—SERPINE1—prostate cancer	6.82e-05	0.000148	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—PIK3CA—prostate cancer	6.81e-05	0.000148	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PIK3CD—prostate cancer	6.81e-05	0.000148	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—SERPINE1—prostate cancer	6.8e-05	0.000148	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—KRAS—prostate cancer	6.75e-05	0.000147	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—PIK3CA—prostate cancer	6.74e-05	0.000147	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—SERPINE1—prostate cancer	6.73e-05	0.000146	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—KRAS—prostate cancer	6.73e-05	0.000146	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—KRAS—prostate cancer	6.66e-05	0.000145	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—FGF2—prostate cancer	6.6e-05	0.000144	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—FGF2—prostate cancer	6.58e-05	0.000143	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—FGF2—prostate cancer	6.52e-05	0.000142	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—NOS3—prostate cancer	6.51e-05	0.000142	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—NOS3—prostate cancer	6.49e-05	0.000141	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—NOS3—prostate cancer	6.43e-05	0.00014	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—JAK2—prostate cancer	6.33e-05	0.000138	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—JAK2—prostate cancer	6.31e-05	0.000137	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—JAK2—prostate cancer	6.25e-05	0.000136	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—PIK3CA—prostate cancer	6.2e-05	0.000135	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PTEN—prostate cancer	6.19e-05	0.000135	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—PIK3CA—prostate cancer	6.18e-05	0.000134	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MDM2—prostate cancer	6.18e-05	0.000134	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MDM2—prostate cancer	6.16e-05	0.000134	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—PIK3CA—prostate cancer	6.12e-05	0.000133	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MDM2—prostate cancer	6.1e-05	0.000133	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—ERBB2—prostate cancer	6.09e-05	0.000132	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—ERBB2—prostate cancer	6.07e-05	0.000132	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—ERBB2—prostate cancer	6.01e-05	0.000131	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PIK3CB—prostate cancer	6.01e-05	0.000131	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PIK3CB—prostate cancer	5.99e-05	0.00013	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PIK3CB—prostate cancer	5.93e-05	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—EP300—prostate cancer	5.9e-05	0.000128	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CXCL8—prostate cancer	5.78e-05	0.000126	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CXCL8—prostate cancer	5.76e-05	0.000125	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CXCL8—prostate cancer	5.7e-05	0.000124	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CDKN1B—prostate cancer	5.64e-05	0.000123	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CDKN1B—prostate cancer	5.62e-05	0.000122	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—AKT1—prostate cancer	5.58e-05	0.000121	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	5.57e-05	0.000121	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—AKT1—prostate cancer	5.56e-05	0.000121	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CASP3—prostate cancer	5.53e-05	0.00012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IL2—prostate cancer	5.52e-05	0.00012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CASP3—prostate cancer	5.51e-05	0.00012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	5.51e-05	0.00012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IL2—prostate cancer	5.5e-05	0.00012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—IL6—prostate cancer	5.49e-05	0.000119	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—IL6—prostate cancer	5.47e-05	0.000119	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CASP3—prostate cancer	5.46e-05	0.000119	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IL2—prostate cancer	5.45e-05	0.000119	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—IL6—prostate cancer	5.42e-05	0.000118	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CCND1—prostate cancer	5.38e-05	0.000117	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CCND1—prostate cancer	5.36e-05	0.000117	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CTNNB1—prostate cancer	5.33e-05	0.000116	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CTNNB1—prostate cancer	5.31e-05	0.000116	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CCND1—prostate cancer	5.31e-05	0.000116	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	5.26e-05	0.000114	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MMP9—prostate cancer	5.22e-05	0.000114	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MMP9—prostate cancer	5.21e-05	0.000113	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CDKN1A—prostate cancer	5.21e-05	0.000113	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PTEN—prostate cancer	5.19e-05	0.000113	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CDKN1A—prostate cancer	5.19e-05	0.000113	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PTEN—prostate cancer	5.18e-05	0.000113	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MMP9—prostate cancer	5.16e-05	0.000112	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	5.14e-05	0.000112	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PTEN—prostate cancer	5.13e-05	0.000112	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—AKT1—prostate cancer	5.07e-05	0.00011	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—AKT1—prostate cancer	5.05e-05	0.00011	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—AKT1—prostate cancer	5e-05	0.000109	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—EP300—prostate cancer	4.95e-05	0.000108	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—EP300—prostate cancer	4.94e-05	0.000107	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—EP300—prostate cancer	4.89e-05	0.000106	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—SRC—prostate cancer	4.82e-05	0.000105	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—SRC—prostate cancer	4.8e-05	0.000104	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—SRC—prostate cancer	4.75e-05	0.000103	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—VEGFA—prostate cancer	4.69e-05	0.000102	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—VEGFA—prostate cancer	4.68e-05	0.000102	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—STAT3—prostate cancer	4.64e-05	0.000101	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—VEGFA—prostate cancer	4.63e-05	0.000101	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—STAT3—prostate cancer	4.63e-05	0.000101	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—STAT3—prostate cancer	4.58e-05	9.97e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PIK3CA—prostate cancer	4.37e-05	9.5e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MYC—prostate cancer	4.32e-05	9.39e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TGFB1—prostate cancer	4.31e-05	9.37e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MYC—prostate cancer	4.3e-05	9.36e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TGFB1—prostate cancer	4.29e-05	9.34e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MYC—prostate cancer	4.26e-05	9.27e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TGFB1—prostate cancer	4.25e-05	9.25e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—EGFR—prostate cancer	4.22e-05	9.18e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—EGFR—prostate cancer	4.21e-05	9.15e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—EGFR—prostate cancer	4.17e-05	9.07e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—KRAS—prostate cancer	3.99e-05	8.68e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—KRAS—prostate cancer	3.98e-05	8.65e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—KRAS—prostate cancer	3.94e-05	8.56e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PIK3CA—prostate cancer	3.66e-05	7.97e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PIK3CA—prostate cancer	3.65e-05	7.94e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	3.62e-05	7.87e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—AKT1—prostate cancer	3.57e-05	7.76e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TP53—prostate cancer	3.54e-05	7.71e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TP53—prostate cancer	3.53e-05	7.69e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TP53—prostate cancer	3.5e-05	7.61e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IL6—prostate cancer	3.24e-05	7.06e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IL6—prostate cancer	3.23e-05	7.04e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IL6—prostate cancer	3.2e-05	6.97e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—AKT1—prostate cancer	2.99e-05	6.51e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—AKT1—prostate cancer	2.98e-05	6.49e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—AKT1—prostate cancer	2.95e-05	6.43e-05	CbGpPWpGaD
